SCHEMBL8282807

SCHEMBL8282807

C=C(c1ccc(C)cc1)N(CCC)CCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.39
TP53 P04637 1/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
EGFR P00533 1/20 0.37
ERBB2 P04626 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
POLB P06746 1/20 0.36
APEX1 P27695 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KCNH2 Q12809 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
GSK3B P49841 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HPGD P15428 2/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22538519 0.92 KCNH2 (0.38) MLYCDTP53ALDH1A1LMNACES2
SCHEMBL21507868 0.83 HPGD (0.40) MLYCDALDH1A1LMNACES2CES1
SCHEMBL21078085 0.82 TP53 (0.47) TP53ALDH1A1LMNACES2CES1
SCHEMBL23280377 0.79 L3MBTL1 (0.40) ALDH1A1LMNAEGFRERBB2KCNH2
SCHEMBL20156934 0.77 HPGD (0.40) MLYCDTP53ALDH1A1LMNAEGFR
SCHEMBL9357131 0.76 CA12 (0.41) MLYCDTP53ALDH1A1LMNACES2
SCHEMBL7967022 0.76 MLYCD (0.64) MLYCDTP53ALDH1A1LMNACES2
SCHEMBL19367916 0.74 TXNRD1 (0.32) NPC1RAB9AKCNH2
SCHEMBL31384410 0.73 CES2 (0.54) MLYCDTP53ALDH1A1LMNACES2
SCHEMBL23717098 0.73 GSK3B (0.37) MLYCDTP53ALDH1A1LMNACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3189041-B1 TETRAHYDROISOQUINOLINE DERIVED PRMT5-INHIBITORS CTXT PTY LTD (AU) 2021-04-28 EP disclosed
WO-2020263186-A1 COMPOUNDS FOR TREATMENT OF CANCER SINOPSEE THERAPEUTICS (SG) 2020-12-30 WO disclosed
WO-2005103055-A1 PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2005-11-03 WO disclosed